Cargando…

The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment

BACKGROUND: We have previously reported that induced pluripotent stem cell (iPSC)-mesenchymal stem cells (MSCs) alleviated asthma inflammation in mice. Long noncoding RNAs (lncRNAs) were recently reported as being involved in the immune responses. However, whether lncRNAs are associated with iPSC-MS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shu-Yue, Fan, Xing-Liang, Yu, Qiu-Ning, Deng, Meng-Xia, Sun, Yue-Qi, Gao, Wen-Xiang, Li, Cheng-Lin, Shi, Jian-Bo, Fu, Qing-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216550/
https://www.ncbi.nlm.nih.gov/pubmed/28057064
http://dx.doi.org/10.1186/s13287-016-0456-3
_version_ 1782491934079582208
author Wang, Shu-Yue
Fan, Xing-Liang
Yu, Qiu-Ning
Deng, Meng-Xia
Sun, Yue-Qi
Gao, Wen-Xiang
Li, Cheng-Lin
Shi, Jian-Bo
Fu, Qing-Ling
author_facet Wang, Shu-Yue
Fan, Xing-Liang
Yu, Qiu-Ning
Deng, Meng-Xia
Sun, Yue-Qi
Gao, Wen-Xiang
Li, Cheng-Lin
Shi, Jian-Bo
Fu, Qing-Ling
author_sort Wang, Shu-Yue
collection PubMed
description BACKGROUND: We have previously reported that induced pluripotent stem cell (iPSC)-mesenchymal stem cells (MSCs) alleviated asthma inflammation in mice. Long noncoding RNAs (lncRNAs) were recently reported as being involved in the immune responses. However, whether lncRNAs are associated with iPSC-MSC immunomodulation in allergic inflammation is still unclear. METHODS: Mice were induced into an asthmatic state and received treatment consisting of iPSC-MSCs. Memory T cells isolated from sensitized mice were challenged and co-cultured with iPSC-MSCs in vitro. Total RNA from the lungs and separated T cells were processed with an lncRNA/mRNA microarray. A series of bioinformatics technologies were used to screen the target lncRNAs. RESULTS: iPSC-MSCs significantly prevented asthma inflammation and decreased the Th2 cytokine levels. Over 1300 lncRNAs were differentially expressed after the induction of asthma, and 846 or 4176 lncRNAs were differentially expressed with iPSC-MSC treatment in mice or in vitro, respectively. After overlapping the differentially expressed lncRNAs produced in a similar manner in mice and in vitro, 23 lncRNAs and 96 mRNAs were selected, in which 58 protein-coding genes were predicted to be potential targets of the 23 lncRNAs. Furthermore, using a series of bioinformatics technologies, 9 lncRNAs co-expressed with the most differentially expressed mRNAs, which were enriched in terms of the immune response, were screened out via Pearson’s correlation coefficient with mRNAs that were involved with inflammatory cytokines and receptors. lncRNAs MM9LINCRNAEXON12105+ and AK089315 were finally emphasized via quantitative real-time PCR validation. CONCLUSIONS: Our results suggested that aberrant lncRNA profiles were present after asthma induction and iPSC-MSC treatment, suggesting potential targets of allergic inflammation and iPSC-MSC-mediated immunomodulation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-016-0456-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5216550
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52165502017-01-09 The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment Wang, Shu-Yue Fan, Xing-Liang Yu, Qiu-Ning Deng, Meng-Xia Sun, Yue-Qi Gao, Wen-Xiang Li, Cheng-Lin Shi, Jian-Bo Fu, Qing-Ling Stem Cell Res Ther Research BACKGROUND: We have previously reported that induced pluripotent stem cell (iPSC)-mesenchymal stem cells (MSCs) alleviated asthma inflammation in mice. Long noncoding RNAs (lncRNAs) were recently reported as being involved in the immune responses. However, whether lncRNAs are associated with iPSC-MSC immunomodulation in allergic inflammation is still unclear. METHODS: Mice were induced into an asthmatic state and received treatment consisting of iPSC-MSCs. Memory T cells isolated from sensitized mice were challenged and co-cultured with iPSC-MSCs in vitro. Total RNA from the lungs and separated T cells were processed with an lncRNA/mRNA microarray. A series of bioinformatics technologies were used to screen the target lncRNAs. RESULTS: iPSC-MSCs significantly prevented asthma inflammation and decreased the Th2 cytokine levels. Over 1300 lncRNAs were differentially expressed after the induction of asthma, and 846 or 4176 lncRNAs were differentially expressed with iPSC-MSC treatment in mice or in vitro, respectively. After overlapping the differentially expressed lncRNAs produced in a similar manner in mice and in vitro, 23 lncRNAs and 96 mRNAs were selected, in which 58 protein-coding genes were predicted to be potential targets of the 23 lncRNAs. Furthermore, using a series of bioinformatics technologies, 9 lncRNAs co-expressed with the most differentially expressed mRNAs, which were enriched in terms of the immune response, were screened out via Pearson’s correlation coefficient with mRNAs that were involved with inflammatory cytokines and receptors. lncRNAs MM9LINCRNAEXON12105+ and AK089315 were finally emphasized via quantitative real-time PCR validation. CONCLUSIONS: Our results suggested that aberrant lncRNA profiles were present after asthma induction and iPSC-MSC treatment, suggesting potential targets of allergic inflammation and iPSC-MSC-mediated immunomodulation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-016-0456-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-06 /pmc/articles/PMC5216550/ /pubmed/28057064 http://dx.doi.org/10.1186/s13287-016-0456-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wang, Shu-Yue
Fan, Xing-Liang
Yu, Qiu-Ning
Deng, Meng-Xia
Sun, Yue-Qi
Gao, Wen-Xiang
Li, Cheng-Lin
Shi, Jian-Bo
Fu, Qing-Ling
The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment
title The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment
title_full The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment
title_fullStr The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment
title_full_unstemmed The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment
title_short The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment
title_sort lncrnas involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216550/
https://www.ncbi.nlm.nih.gov/pubmed/28057064
http://dx.doi.org/10.1186/s13287-016-0456-3
work_keys_str_mv AT wangshuyue thelncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT fanxingliang thelncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT yuqiuning thelncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT dengmengxia thelncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT sunyueqi thelncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT gaowenxiang thelncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT lichenglin thelncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT shijianbo thelncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT fuqingling thelncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT wangshuyue lncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT fanxingliang lncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT yuqiuning lncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT dengmengxia lncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT sunyueqi lncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT gaowenxiang lncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT lichenglin lncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT shijianbo lncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment
AT fuqingling lncrnasinvolvedinmouseairwayallergicinflammationfollowinginducedpluripotentstemcellmesenchymalstemcelltreatment